[Effectiveness of bemitil in recurrent erysipelas].
Ratnikova LI · 1991 · Klinicheskaia meditsina; 1991 Jul
Study findings
In 66 patients with recurrent erysipelas, adding Bemitil to conventional care was associated with faster resolution of symptoms and earlier discharge than adding placebo.
- Population and setting
- Human report; see summary and review scope
- Evidence type
- Human comparative study
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Allocation, masking, group details and numerical outcomes require full-text appraisal; findings do not establish benefit in healthy users.
- Possible overlap between these 1991 erysipelas reports remains unresolved; do not count them as independent replication.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Ratnikova LI. [Effectiveness of bemitil in recurrent erysipelas]. Klinicheskaia meditsina; 1991 Jul 1991.
Molekul research summary: https://molekul.io/research/bemitil-extra-1942990. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry